Tag: Jim O’Neill
Register now
Posted by admin | May 19, 2017 | Uncategorized | 0
“Is that all?” Very little investment needed to sa...
Posted by admin | Sep 17, 2016 | Introduction | 0
Welcome
Posted by admin | Jul 11, 2016 | Introduction | 0
Introduction by Jean Carlet
Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0
2017
PopularResponses To Antimicrobial Resistance In All Policies – The German AMR Strategy
by admin | Jul 19, 2017 | 2017, 2017 - 1, Governance | 0
Karin Knufmann-Happe, Director General For Health Protection, Disease Control and Biomedicine, Federal Ministry of Health, Germany In 2015, the German Antibiotic Resistance Strategy, DART 2020, was approved by the Federal...
-
MedTech Europe
by admin | May 19, 2018 | Supporters 2017 | 0
-
On the value of viewing Antimicrobial Resistance as a threat to international security
by admin | Jul 31, 2017 | 2017, Governance | 0
-
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
2017

MedTech Europe

Institut Merieux

Less than one cent to save a patient fro...
A National Action Plan to Contain Antimi...

MedTech Europe

The Global Point Prevalence Survey ̵...

Because taking care is the essence of he...
Healthcare
PopularDrug-Resistant Tuberculosis: What Is The Situation, What Are The Needs To Roll It Back?
by admin | Jul 26, 2017 | 2017, Healthcare | 0
Dr Karin Weyer, Coordinator, Laboratories, Diagnostics and Drug Resistance; Dr Dennis Falzon, Medical Officer; Dr Ernesto Jaramillo, Team Leader, Drug-Resistant TB Policies; Dr Matteo Zignol, Team Lead, Global Project on...
-
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back
by admin | Jul 31, 2017 | 2017, Healthcare | 0
-
Intensive care units as epicentres for antimicrobial resistance development
by admin | Jul 31, 2017 | 2017, Healthcare | 0
-
Improving rational antibiotic treatment of common childhood conditions in Uganda
by admin | Jul 31, 2017 | 2017, Healthcare | 0
Economics and Innovation
Top RatedThe role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
All
LatestPhage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
- All
- Diagnostics
- Rational use of antibiotics
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
Augmented* medicine for all
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
-
Diagnostics come of age to combat antimicrobial resistance
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
-
Diagnostic innovation for antimicrobial resistance
by admin | Jul 11, 2016 | Diagnostics
-
Medical value of the rapid MRSA/SA screening in emergency surgery
by admin | Jul 11, 2016 | Diagnostics
The evolution of the global antibiotic resistance partnership
by admin | Sep 12, 2016 | Rational use of antibiotics
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Categories
- 2016 (21)
- 2016 frontpage (4)
- 2017 (37)
- Alternatives to Antibiotics (2)
- Economics and Innovation (4)
- Governance (8)
- Healthcare (8)
- One Health (7)
- Supporters 2017 (6)
- 2017 frontpage (4)
- 2018 frontpage (5)
- 2018 frontpage français (4)
- 2019-1 (1)
- 2019-2 (1)
- 2019-3 (1)
- 2019-4 (1)
- Introduction (4)
- R&D innovation (5)
- Sponsored features (6)
- Supporters (3)
- Uncategorized (2)